Roche’s part IIb research of prasinezumab failed to fulfill main endpoint, however suggests doable medical profit in treating early-stage Parkinson’s illness
The PADOVA research confirmed a numerical delay in motor development and constructive…
RFK Jr. accused the FDA of suppressing hydroxychloroquine. Now the research that instructed its use in treating COVID has been retracted.
Elsevier printed its official retraction on Tuesday. Learn more #RFK #accused #FDA…
